CLARRISSA GOBER: Open Payments
NPI 1881015162 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 105 payments from 17 companies in 2025. Trend: 2023 $2,044 · 2024 $1,913 · 2025 $1,760
Food & beverage: $1,639Education: $121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $588 |
| Teva Pharmaceuticals USA, Inc. | 8 | $183 |
| Lundbeck LLC | 10 | $182 |
| UCB, Inc. | 11 | $177 |
| Alexion Pharmaceuticals, Inc. | 4 | $116 |
| Neurelis, Inc. | 2 | $79 |
| Lilly USA, LLC | 4 | $72 |
| PFIZER INC. | 3 | $59 |
| Amneal Pharmaceuticals LLC | 3 | $53 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
Products named: QULIPTA, UBRELVY, ULTOMIRIS, REXULTI, Briviact, BOTOX, Rystiggo, VYEPTI.
Industry payments across AZ — which companies pay providers there.
